Carolyn Myers, CEO of Fendx Technologies Inc, joined Proactive to share exciting progress on the company’s REPELWRAP film. After completing the pilot manufacturing phase in collaboration with Dunmore International Inc., Fendx is moving to the next critical step—evaluating the film’s effectiveness in real-world settings.
Myers emphasized that this phase is crucial for understanding how REPELWRAP, a protective surface film, performs outside of controlled environments. The company has pre-announced various test sites, including locations in the healthcare industry, which remains a primary focus. However, Fendx also sees significant opportunities in high-traffic settings such as arenas, schools, and entertainment venues.
Fendx’s ongoing partnerships will play a pivotal role in expanding into various vertical markets. Myers highlighted the company’s plans to identify distributors to support this growth. The insights gained from the real-world testing phase will guide Fendx in finalizing REPELWRAP for commercial production, marking a major milestone in the company’s mission to innovate in protective surface technologies.
#proactiveinvestors #otcqb #fendx #cse #fndx #NanoCoating #InfectionControl #HealthcareInnovation #PathogenPrevention #Commercialization #SurfaceProtection #TechForGood #HealthcareSafety #ProactiveInvestments#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews